State senators are now considering House Bill 1114, which seeks to put a $25 cap on the price of insulin for people on the state’s PERS plan and people who get insurance from the large employer health ...

If passed, the Affordable Insulin Now Act would apply the cap across both private health insurance and Medicare plans, and according to Schumer would cut the cost of a 30-day supply of insulin for ...

Neither is likely to pass, but medical professionals hope to move the needle on ways to make healthcare more affordable.

North Dakota lawmakers are hearing more testimony about a bill that would reduce the cost of insulin and related medical devices. The bill was written by North Dakota Public Employee Retirement System ...

Media reports before the Inflation Reduction Act price cap said out-of-pocket costs for insulin could cross $1,400 a month, roughly 4,000% of the $35 cap under the Inflation Reduction Act.

Gov. Gavin Newsom promised a “2024 delivery” for a state-branded, low-cost insulin. It still is not here, and the American Diabetes Association says the lag is hurting diabetics who need a low ...

In the past decade, insulin prices have reached exorbitant levels that many patients cannot afford, even with health insurance. While some of these costs ...

Democratic Senator Scott Wiener from San Francisco recently resurrected a bill — now Senate Bill 40 — to cap insulin prices that Newsom vetoed last year. His veto message said CalRx made it ...

The out-of-pocket cost cap of $£35 at participating retail pharmacies (circa 85% of pharmacies) for people with commercial insurance using Lilly insulin is effective immediately. Meanwhile ...

HORACE, N.D. — A bill in North Dakota's Legislature is calling for a cap on the price of insulin. House Bill 1114 already passed through the House, by a margin of 59-27-7 in February, and still needs ...

“That is absolutely not the case.” Wiener, a San Francisco Democrat, authored the most recent attempts to cap patient spending on insulin at $35 per month and regulate pharmacy benefit ...

“That is absolutely not the case.” Wiener, a San Francisco Democrat, authored the most recent attempts to cap patient spending on insulin at $35 per month and regulate pharmacy benefit ...